3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Sarcoma
3
Prostatic Neoplasms
3
Stomach Neoplasms
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Thrombosis
1
Stroke
1
Skin Neoplasms
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Resectable Pancreatic Carcinoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Nevus, Pigmented
1
Neoplasms
1
Mesothelioma, Malignant
1
Melanoma
1
Liver Neoplasms
1
Liposarcoma
1
Glioma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Interventions
Pemetrexed
9
Cisplatin
9
pembrolizumab
5
defactinib
3
Cyclophosphamide
3
sodium thiosulfate
2
Radiotherapy, Intensity-Modulated
2
Platinum
2
Immunoenzyme Techniques
2
Doxorubicin
2
1,2-diaminocyclohexaneplatinum II citrate
2
vatalanib
1
spartalizumab
1
osimertinib
1
nintedanib
1
liposomal doxorubicin
1
cabozantinib
1
antineoplaston AS 2-1
1
antineoplaston A10
1
amatuximab
1
alvocidib
1
aldesleukin
1
X-Rays
1
VS-5584
1
Trabectedin
1
Tetrahydrouridine
1
Specimen Handling
1
Ramucirumab
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Mesothelioma, Malignant
×
X-Rays
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled